Locations:
Search IconSearch
October 23, 2020/Neurosciences

Surgery For Axial Neck Pain: Who Is a Good Candidate And Who Isn’t

Strong patient-physician communication and a conservative approach are essential for recovery

Neck X ray

by Jonathan J. Rasouli, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Neck pain is a tricky clinical problem, both for the patient and the healthcare provider. While axial neck pain is generally not an indication for surgical intervention, it often co-exists with cervical radiculopathy and myelopathy. We know that degenerative disc disease often considered a normal process of aging, can cause pain due to the altered viscoelasticity of desiccated and aged intervertebral discs. When subjected to normal physiologic forces, degenerative discs exhibit greater deformation and strain, thus altering the normal load-bearing homeostasis of the cervical spine. As one can imagine, this is quite a painful situation!

While many adults will experience at least one substantial neck pain crisis in their lifetime, the vast majority of these episodes are benign and a self-limited process. The majority of neck pain episodes are due to myofascial etiologies. As is the case with myofascial low back pain, we know that myofascial neck pain rarely improves with surgical intervention. So when do we, as surgeons, operate on patients with degenerative cervical disease who present with predominantly neck pain? As with many questions in spine surgery, the answer is not so clear. In patients who present with axial neck pain of greater than 12-weeks duration and have failed initial conservative measures, there are some circumstances where surgical intervention can be considered.

The type of pain should direct the treatment plan

In general, patients with degenerative cervical spondylosis who present with refractory neck pain that is not mechanical will rarely improve with surgery. However, there are some specific subsets of neck pain patients who have demonstrated symptomatic relief in small case series: facetogenic pain and discogenic pain. Patients with discogenic neck pain, or pain that is attributable to a highly degenerative intervertebral disc, demonstrated some relief of symptoms after anterior cervical discectomy and fusion (ACDF) in a small case-series by Palit and colleagues.

Advertisement

In this study, neck pain patients who had a single degenerative disc, failed conservative management and had a positive concordant discogram demonstrated improvements in visual analog scale pain and neck disability index after ACDF. Similarly, patients who have axial neck pain that is attributable to a degenerative facet joint can potentially improve after cervical fusion; however, the body of literature supporting this is lacking. In general, there is weak literature to support surgical intervention for axial neck pain when the patient has exhausted virtually all conservative options and there is a potential pain generator. It should also be mentioned that patients with cervical spine deformity, most commonly kyphosis, can often present with neck pain due to compensatory overactivation of the trapezius muscle in order to maintain a horizontal gaze and straight posture (kyphosis-trapezius sign).

When to take a surgical approach

I do not believe neck pain in the absence of cervical spine deformity or radicular and/or myelopathic symptoms is a good indication for surgery. We know that conservative measures such as the temporary use of a soft collar, lifestyle modifications, non-opioid analgesics and occasionally botulinum toxin (Botox) injections are very successful in treating axial neck pain. The current data for surgical intervention in patients with neck pain is spotty at best. Posterior surgical approaches reserved for procedures like cervical laminectomy/fusion and laminoplasty have been shown to increase post-operative neck pain; furthermore, the natural history of axial neck pain is generally benign and self-limiting. A patient with constant, unremitting pain that does not respond to any treatments should be closely evaluated for the presence of co-morbid psychiatric conditions that may somaticize as neck pain. Most importantly, obtain a thorough and accurate history and physical exam, maintain clear and honest lines of communication between the patient and physician and avoid the “trap” of overtreatment.

Advertisement

Axial neck pain is best treated with conservative therapies and a close physician-patient relationship. There are rare instances, which are still controversial, in which surgical intervention may be of some benefit. These instances are primarily in the setting of discogenic neck pain; however, this is primarily a diagnosis of exclusion. Once again, the most important therapeutic goal is to avoid overtreatment and polypharmacy. We know the vast majority of axial neck pain episodes are a self-limited process, so we should strive to educate our patients and set realistic expectations for recovery.

Bibliography:

Boden SD, McCowin PR, et al. Abnormal magnetic resonance scans of the cervical spine in aymptomatic subjects. A prospective investigation. J Bone Joint Surg Am 1990; 72(8): 1178-1184.

Palit M, Schofferman J, Goldthwait N, et al. Anterior discectomy and fusion for the management of neck pain. Spine 1999; 24(21): 2224-2228.

Rinkus K, Rhee JM. Evaluation of axial neck pain – Who is a surgical candidate and who isn’t: how to manage the nonoperative treatment, how to work up the pathology. Textbook of Spinal Surgery, 3rd Volume 1 . Chapter 21. Editor: Bridwell, KH and DeWald RL. 2011.

Advertisement

Related Articles

gloved hand holding blood vial with neuropathology slide in background
October 10, 2025/Neurosciences/Epilepsy
Blood-Based Epigenetic Biomarkers Differentiate Focal Cortical Dysplasia Subtypes

Paired blood and brain tissue methylation findings raise prospect of noninvasive precision diagnosis

young man using walking canes on a city street
Vidofludimus for Progressive MS: No Impact on Brain Atrophy but Hints of a Role for Disability

Mixed results from phase 2 CALLIPER trial of novel dual-action compound

illustration of myelin sheaths wrapped around neuron axons
Revised McDonald Criteria for Multiple Sclerosis: A Big Step Toward Biomarker-Driven Diagnosis

A co-author of the new recommendations shares the updates you need to know

Dr. Jason Savage against a decorative background with podcast button overlay
October 2, 2025/Neurosciences/Podcast
Essentials of Revision Spine Deformity Surgery (Podcast)

Success for these complex operations requires judicious patient selection and presurgical patient optimization

physician talking with a patient in medical office
De-Escalation of Disease-Modifying Therapies in MS: A Real-World Look at Outcomes

Rebound risk is shaped by patient characteristics and mechanism of action of current DMT

woman speaking to a doctor
Tool Shows Promise for Individualized Decision Support on Stopping Disease-Modifying Therapy for Multiple Sclerosis

First-of-kind prediction model demonstrates high consistency across internal and external validation

health worker preparing infusion of injectable drug
Ocrelizumab Associated With Nearly Twofold Increase in Serious Infections Vs. Platform Injectables in Multiple Sclerosis

Real-world study also finds no significant rise in ocrelizumab-related risk with advanced age

two brain MRIs side by side with red circles on them
Cognitive Impairment in Multiple Sclerosis Linked to Rapid Thalamic Atrophy

Machine learning study associates discrete neuropsychological testing profiles with neurodegeneration

Ad